200 DROGAS
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Boniva (ibandronate)<br />
Pronunciation: iban·dro·nate<br />
Classification: Bisphosphonate<br />
IFU: X<br />
Route: oral tablet & intravenous solution<br />
Dosage: 2.5 mg ; 150 mg ; 3 mg/3 mL<br />
Action: Treating osteoporosis (weak bones) in women who are past menopause.<br />
Adverse Reaction: Bladder pain, bloody/cloudy urine, & chest pain<br />
Interactions: botulism immune globulin, cidofovir, & diatrizoate<br />
Byetta(Exenatide)<br />
Pronunciation: Ex-en-a-tide<br />
Classification: GLP-1 receptor agonist<br />
IFU: Type 2 diabetes mellitus<br />
Route: by injection<br />
Dosage: 5mcg , 10mcg<br />
Action: Mimics the action of incretin which promotes endogenous insulin secretion and<br />
promotes other mechanisms of glucose-lowering<br />
Adverse Reaction: Dizziness, headache, jitteriness, and weakness.<br />
Interactions: Bexarotene, gatifloxacin, targeting, and tequin.<br />
Bystolic (Nebivolol)<br />
Pronunciation: ne-BIV-oh-lol<br />
Classification: Beta-blocker<br />
IFU: Hypertension<br />
Action: Lowers blood pressure which may lower risk of a stroke or heart attack.<br />
Dosage: 2.5mg, 5mg, 10mg, and 20mg tablets<br />
Route: Oral<br />
Adverse Reaction: Mild headache, bloating or swelling of the face, arm, hands, lower legs or<br />
feet.<br />
Interactions: Amlodipine, Atorvastatin, Furosemide, Losartan, and Prednisone.<br />
Caduet (amlodipine / atorvastatin)<br />
Pronunciation: am LOE di peen and a TOR va sta tin<br />
Classification: CCB / HMG -CoA reductase<br />
IFU: hypertension / hyperlipidemia<br />
Route: P.O.<br />
Dosage: tablet 2.5mg, 10mg<br />
Action: reduces levels of bad cholesterol and triglycerides, increases good level of cholesterol,<br />
and relaxes blood vessels<br />
Adverse Reaction: dizziness, edema, palpitations<br />
Interactions: increase blood pressure with ibuprofen and naproxen, increase risk for muscle and<br />
liver problems when combined with products that contain lovastatin